RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Small extracellular vesicle-loaded bevacizumab reduces the frequency of intravitreal injection required for diabetic retinopathy.

Small extracellular vesicle-loaded bevacizumab reduces the frequency of intravitreal injection required for diabetic retinopathy.

Add to Collection
2023 Others Fist_Author_Year_PM

Full Author : ['Reddy, Shivakumar K', 'Ballal, Abhijna R', 'Shailaja, S', 'Seetharam, Raviraja N', 'Raghu, Chandrashekar H', 'Sankhe, Runali', 'Pai, Kanthilatha', 'Tender, Tenzin', 'Mathew, Mary', 'Aroor, Annayya', 'Shetty, Ashok K', 'Adiga, Shalini', 'Devi, Vasudha', 'Muttigi, Manjunatha S', 'Upadhya, Dinesh']
Journal Title : Theranostics
Chapter : Section3
Journal Year : 2023
Cited by : Not Available

Diabetic retinopathy (DR) is associated with retinal neovascularization, hard exudates, inflammation, oxidative stress and cell death, leading to vision loss. Anti-vascular endothelial growth factor (Anti-VEGF) therapy through repeated intravitreal inject.....

Keywords : ["small extracellular vesicleloade bevacizumab reduce", "intravitreal injection require", "diabetic retinopathy", "frequency"]